JP2941160B2 - Relief agent for shingles pain - Google Patents

Relief agent for shingles pain

Info

Publication number
JP2941160B2
JP2941160B2 JP5337886A JP33788693A JP2941160B2 JP 2941160 B2 JP2941160 B2 JP 2941160B2 JP 5337886 A JP5337886 A JP 5337886A JP 33788693 A JP33788693 A JP 33788693A JP 2941160 B2 JP2941160 B2 JP 2941160B2
Authority
JP
Japan
Prior art keywords
pain
plant
shingles
day
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP5337886A
Other languages
Japanese (ja)
Other versions
JPH07188043A (en
Inventor
勝夫 仁科
晴義 仁科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP5337886A priority Critical patent/JP2941160B2/en
Publication of JPH07188043A publication Critical patent/JPH07188043A/en
Application granted granted Critical
Publication of JP2941160B2 publication Critical patent/JP2941160B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、クロバナヒキオコシの
植物体又はその抽出物を含んで成る、帯状疱疹に起因す
る苦痛の緩和剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an agent for alleviating pain caused by herpes zoster, comprising a plant of black crab sprouts or an extract thereof.

【0002】[0002]

【従来の技術】帯状疱疹は、帯状ヘルペス又は単にヘル
ペスとも言われ、水痘−帯状疱疹ウイルス感染症であ
り、帯状に配列する発疹と末梢神経症状の合併を特徴と
し、平均した罹患のほかに流行を見ることがあるが、む
しろ高齢者に多発する。誘因も前駆症状もなしに突然発
病することが多い。出血性又は壊疸性の経過をとること
もあり、多分に警戒される病気である。
BACKGROUND OF THE INVENTION Shingles, also known as herpes zoster or simply herpes, is a varicella-zoster virus infection, characterized by a combination of rash arranged in a band and peripheral nerve symptoms. May be seen, but rather frequently in the elderly. It often occurs suddenly without triggers or prodromes. It may have a bleeding or necrotic course and is a disease that is most likely to be watched for.

【0003】帯状疱疹に伴う痛みは、若年層では軽いと
されるが、高齢者では強烈である傾向がある。かつ、皮
疹治癒後も後遺症として痛みが軽減せず、数年にわたっ
て持続する症例が少なくない。これは帯状疱疹後の神経
痛と言われ、全患者平均ではその説に若干の差異はある
が、10%前後とされるものの、60歳以上では全例に
起こるとして警戒される。発生機序は不明であり、予防
法、治療法は確立していない。
[0003] The pain associated with shingles is said to be mild in the young, but tends to be severe in the elderly. In addition, the pain does not decrease as a sequela even after healing of the eruption, and many cases persist for several years. This is said to be postherpetic neuralgia, and although there is a slight difference in the theory on average among all patients, it is around 10%, but it is cautioned that it will occur in all cases over the age of 60. The mechanism is unknown, and no preventive or therapeutic methods have been established.

【0004】ヘルペスウイルス感染症に対する抗ウイル
ス剤は、近時アシクロビル、ビダラビンなどが開発さ
れ、治療に大きく貢献しているが、なお未解決のものと
して、帯状疱疹に伴う、乃至帯状疱疹後の神経痛治療が
残っているのが、医療現場の現状である。
As antiviral agents for herpes virus infections, acyclovir, vidarabine and the like have recently been developed and have greatly contributed to treatment. However, as unsolved problems, neuralgia associated with shingles or postherpetic neuralgia has been solved. What remains of treatment is the current state of medical practice.

【0005】帯状疱疹に伴う痛みに対しては、消炎鎮痛
剤とビタミンB12剤との内服、局所麻酔剤のリドカイン
の投与、ノイロトロピンの内服などが行なわれている
が、各種鎮痛剤の試みがなされながら、少なくとも大多
数の患者に有効であるとされる鎮痛剤は見いだされてい
ない。
[0005] with respect to pain associated with herpes zoster, oral and anti-inflammatory agent and vitamin B 12, the dosage of lidocaine local anesthetic agents, although such oral neurotropins is being performed, attempts various analgesics Nevertheless, no analgesic has been found to be effective at least in the majority of patients.

【0006】例えば末期癌患者に使用される鎮痛剤であ
る麻薬は、有用なものではあるが、患者個々の適量を見
出すことが極めて困難である医薬であると共に、麻薬で
あるゆえの習慣性が不可避であるため、末期癌患者と違
って治癒の可能性が圧倒的に大きい帯状疱疹患者に、麻
薬を多用することができない。
For example, narcotics, which are analgesics used for terminal cancer patients, are useful, but it is extremely difficult to find an appropriate amount for each individual patient. Because it is inevitable, unlike in terminal cancer patients, narcotics cannot be heavily used in shingles patients who have an overwhelming possibility of cure.

【0007】しかも鎮痛効果に優れるとされるモルヒネ
も、決して万能薬ではなく、筋攣縮痛、胃膨満痛などと
共に、ヘルペス後神経痛には効かないとされている。こ
のような状態で、帯状疱疹患者の帯状疱疹による苦痛
は、通常の鎮痛剤とか精神安定剤によって僅かに軽減さ
れることを期待乏しく待ちながら、我慢する以外に方法
はない。かつ、帯状疱疹後遺症としての神経痛を予防す
る療法は、現在のところないのが実情である。
[0007] Moreover, morphine, which is said to have an excellent analgesic effect, is not a panacea, and is not effective against post-herpetic neuralgia along with muscle spasm and gastric bloating. Under these conditions, there is no other way but to endure the shingles pain of patients with herpes zoster, with little hope that it will be slightly alleviated by usual painkillers and tranquilizers. At present, there is no therapy for preventing neuralgia as a sequela of herpes zoster.

【0008】[0008]

【発明が解決しようとする課題】本発明は、帯状疱疹に
起因する痛みや苦しみを効果的に緩和又は解消し、しか
も副作用のない医薬、更には帯状疱疹に後遺症の神経痛
を伴わせない医薬が、強く求められている現状に鑑み、
これらの課題を解決する医薬を提供するものである。
DISCLOSURE OF THE INVENTION The present invention relates to a medicament for effectively relieving or eliminating pain and suffering caused by herpes zoster and having no side effects, and a medicament which does not cause herpes zoster to have neuralgia of sequelae. , In view of the current strong demands,
It is intended to provide a medicine which solves these problems.

【0009】[0009]

【課題を解決するための手段】本発明者は、クロバナヒ
キオコシ植物の薬効を種々の面から検討する過程で、該
植物の植物体又はその抽出物が、帯状疱疹に起因する痛
み又は苦しみ、高齢者に耐え切れない激痛の解消に極め
て効果的であり、しかも副作用がなく、更に該植物体又
はその抽出物を服用して帯状疱疹に起因する苦痛を逃れ
た患者には、帯状疱疹後遺症の神経痛が全く見られない
という、それぞれ驚くべき事実を見いだし、本発明を完
成した。
Means for Solving the Problems In the course of examining the medicinal properties of a black clover plant from various aspects, the present inventor found that a plant or an extract thereof suffered from pain or suffering due to herpes zoster, It is extremely effective in relieving severe pain that cannot be tolerated, has no side effects, and in patients who have taken the plant or its extract and escaped the pain caused by herpes zoster, neuralgia of herpes zoster sequelae. The present inventors have found the surprising fact that they cannot be seen at all, and completed the present invention.

【0010】従って本発明は、クロバナヒキオコシの植
物体又はその抽出物を含んで成る、帯状疱疹に起因す
る、及びその後遺症の、痛み及び/又は苦しみの症状
の、緩和又は解消のための医薬を提供するものである。
[0010] Accordingly, the present invention provides a medicament comprising a plant of Chlamydomonas reinhardtii or an extract thereof, for alleviating or eliminating the symptoms of pain and / or suffering due to and subsequent to shingles. Is what you do.

【0011】[0011]

【具体的な説明】クロバナヒキオコシ植物は、ラブドシ
ア・トリコカルバ(Rabdosiatrichoca
rpa)の学名を有し、また、イソドン・ジャポニクス
・カラ(Isodon japonicus Kar
a)、プレクトランサス・ジャポニクス・コイツ(Pl
ectranthus japonicus Koid
z)、アメシスサンサス・ジャポニカ(Amethys
thanthus japonica)、イソドン・ト
リコカルパス(Isodon trichocarpu
s)等としても記載されている。
[Detailed description] The Kurobana chickpea plant is Rabdosia trichocarba.
rpa) and has the scientific name of Isodon japonics Kara.
a), Plectranthus Japonics Koitsu (Pl
Ectranthus japonicus Koid
z), Amesis Sansas Japonica (Amethys)
anthanus japonica, Isodon trichocarpu
s) and the like.

【0012】クロバナヒキオコシは、古来山野に自生す
る宿根多年草の植物で、延命草等と称されることもあ
り、民間健胃薬として使用されている。本発明において
は、クロバナヒキオコシの植物体又はその抽出物を使用
することができるが、目的とする薬効などの観点から、
植物体を使用するのが特に好ましい。使用する植物体の
部分は特に限定されず、根、葉、茎などいずれを使用し
てもよい。
[0012] Kurobana Hikiokoshi is a perennial perennial plant that grows naturally in the ancient mountains and is sometimes referred to as prolonged life grass, and is used as a private stomachic. In the present invention, it is possible to use a plant of Kurobana chickpea or an extract thereof, from the viewpoint of the intended medicinal effect and the like,
It is particularly preferred to use plants. The plant part to be used is not particularly limited, and any of roots, leaves, stems and the like may be used.

【0013】しかしクロバナヒキオコシは宿根多年生の
植物であり、種子による繁殖も勿論可能であるが、地上
部を刈り取った後、残された根から翌年新芽が生じて再
度植物体が形成されるため、根部を残して地上部を使用
するのが、植物体を毎年安定して採取するという実際的
見地から好ましい。本発明医薬の製造に当たっては、例
えば刈り取った植物体から汚れや異物を除去し、好まし
くはこれを乾燥し、しかる後切断、破砕、粉砕等の処理
を行う。
[0013] However, Kurobana Hikiokoshi is a perennial plant of the root, and can of course be propagated by seeds. However, after cutting the aerial part, a sprout is formed from the remaining roots in the next year and the plant body is formed again. It is preferable from the practical point of view that the plant body is stably collected every year using the above-ground part while leaving. In the production of the medicament of the present invention, for example, dirt and foreign matters are removed from the mown plants, preferably dried, and then subjected to treatment such as cutting, crushing, and crushing.

【0014】粉剤として使用することもでき、又はこれ
をカプセルに充填してカプセル剤として供することもで
きる。更に、粉砕したものをそのまま、或は医薬の製造
に常用されている結合剤、例えば澱粉等と共に打錠して
錠剤とすることもでき、その錠剤を糖衣錠等で被覆して
もよい。これらの製剤化に当たっては、薬効成分として
クロバナヒキオコシの植物体のみを使用することも、ま
た他の適当な薬効成分を組合わせて使用することもでき
る。
[0014] It can be used as a powder, or it can be filled in a capsule and provided as a capsule. Further, the pulverized product may be tabletted as it is or with a binder commonly used in the production of pharmaceuticals, for example, starch, etc., and the tablet may be coated with a sugar-coated tablet or the like. In formulating these preparations, it is possible to use only a plant of black crab sprouts as a medicinal ingredient or to use a combination of other appropriate medicinal ingredients.

【0015】なお、クロバナヒキオコシの抽出物を得る
には、植物体を乾燥し、好ましくはこれを小片に切断又
は破砕し、次いでこれを熱水、例えば沸騰水によって抽
出する。所謂煎液とすればよい。また所望により、こう
して調製した抽出液を常法、例えば減圧濃縮等により濃
縮して、濃縮液又は濃縮物にすることもでき、更に凍結
乾燥、噴霧乾燥等により乾燥抽出物にすることもでき
る。
[0015] To obtain an extract of Kurobana cypress, the plant is dried, preferably cut or broken into small pieces, and then extracted with hot water, for example, boiling water. What is called a decoction may be used. If desired, the extract thus prepared can be concentrated by a conventional method, for example, concentration under reduced pressure to obtain a concentrated solution or a concentrate, and further, can be made into a dry extract by freeze-drying, spray-drying or the like.

【0016】本発明医薬により、帯状疱疹に起因する痛
み及び/又は苦しみ、乃至その後遺症である帯状疱疹後
の神経痛を緩和又は解消しようとする場合、成人1人1
日当たりクロバナヒキオコシ植物体乾燥体に換算して1
〜10g、通常2〜5gを経口投与する。この量を1日
2〜3回に分けて投与するのが好ましいが、1回で投与
してもよく、また更に多数回に分けて投与してもよい。
When it is intended to relieve or eliminate the pain and / or suffering caused by herpes zoster and the neuralgia after herpes zoster, which is a sequela thereof, with the medicament of the present invention, one adult person
1 per day in terms of dried black clover plant
Orally, 10 to 10 g, usually 2 to 5 g. It is preferable to administer this amount in two or three times a day, but it may be administered once or in a number of times.

【0017】本発明に使用するクロバナヒキオコシは、
古来民間療法において健胃薬として使用されて来たこと
から、毒性が極めて少ないことは明らかである。
The black clover which is used in the present invention is
Clearly, it has very low toxicity since it has been used as a stomachic in folk medicine since ancient times.

【0018】[0018]

【発明の効果】本発明医薬を、帯状疱疹の患者に、現在
行われている抗ウイルス剤治療と併行して投与した場
合、効果が早く出る場合には投与開始間もなく、また効
果が遅く出る場合でも2週間目頃から、帯状疱疹による
苦痛は著しく緩和され、かつ解消される。副作用は全く
ない。また本発明医薬の投与によって帯状疱疹の苦痛を
逃れた患者は、抗ウイルス剤等による治療によって発疹
が治癒した後、帯状疱疹の後遺症としての神経痛を全く
経験しない。
EFFECT OF THE INVENTION When the medicament of the present invention is administered to a patient with shingles concurrently with an antiviral drug treatment currently being carried out, if the effect is early, it is not immediately after the start of administration, and the effect is late. However, from about the second week, the pain caused by shingles is remarkably reduced and eliminated. There are no side effects. Patients who have escaped the shingles pain by administration of the medicament of the present invention do not experience any neuralgia as a sequela of shingles after the rash has been cured by treatment with an antiviral agent or the like.

【0019】[0019]

【実施例】次に実施例により、この発明を更に具体的に
説明する。臨床例においては既に30例を越す成功例
を、しかも例外なく得ているが、その代表例を記述す
る。
Next, the present invention will be described more specifically with reference to examples. In clinical cases, more than 30 successful cases have already been obtained without exception, and representative examples are described below.

【0020】実施例1本剤の製造例 クロバナヒキオコシの地上部植物体約10kgを採取し、
異物を除去し、次に水で洗い、水を切った後、温風乾燥
機により十分に乾燥した。この際、乾燥を早めるため、
乾燥の途中で植物体を細断した。乾燥が終了した後、細
断された植物体を粉砕し、乾燥粉末(約3kg)を得た。
Embodiment 1 About 10 kg of above-ground plants of Kurobana HIOKIKO of the production example of this agent were collected,
Foreign matter was removed, then washed with water, drained, and then sufficiently dried with a hot air drier. At this time, to speed up drying,
Plants were shredded during drying. After the drying was completed, the shredded plants were pulverized to obtain a dry powder (about 3 kg).

【0021】この粉末は粉剤として使用することができ
る。他方、この粉末を、好ましくは0.25〜0.5g
ずつカプセルに充填することにより、カプセル剤を製造
することができる。前記の粉末に適当量の水を加えて練
和し、これを顆粒化して乾燥し、打錠機によって打錠
し、植物体の乾燥粉末0.25gを含有する錠剤を製造
した。
This powder can be used as a powder. On the other hand, 0.25 to 0.5 g of this powder is preferably used.
By filling the capsules one by one, a capsule can be produced. The powder was mixed with an appropriate amount of water, kneaded, granulated, dried and tableted with a tableting machine to produce a tablet containing 0.25 g of a dry plant powder.

【0022】実施例2本剤の臨床例 (1)75歳の男子 2年前から脳梗塞により日常生活に多少の不自由を感じ
ていたが、腹部に痛みを覚え、2〜3日後米粒大の水疱
を生じ、帯状疱疹と診断された。抗ウイルス剤(アシク
ロビル800mgづつ、毎食後1日3回)による治療中激
しい痛みが持続したが、投与された鎮痛剤(チアプロフ
ェン200mgづつ、毎食後1日3回)は全く効果を示さ
なかった。診断後10日目から、それら鎮痛剤の投与を
止め、本発明クロバナヒキオコシ植物体0.25gを1
錠とする本剤を、1日3回各4錠経口服用したところ7
日目から痛みを全く知覚しなくなった。
Embodiment 2 FIG. Clinical case of this drug (1) A 75-year-old boy Two years ago, he felt some inconvenience in his daily life due to cerebral infarction. Herpes was diagnosed. Antivirals (Asik
Robil (800 mg each, three times a day after each meal) continued to be severely painful during treatment, but the administered analgesic (Tiaprof
(200 mg each, three times a day after each meal) had no effect. On day 10 after the diagnosis, the administration of the analgesics was stopped, and 0.25 g of the Kurobana sprouts plant of the present invention was added to 1
This tablet was taken orally three times a day for 4 tablets each.
From the day, I did not notice any pain.

【0023】本剤の服用を更に1週間続けた後、皮疹の
治癒が見られ始めた頃からその服用を休止したが、痛み
の再発は全く見られず、懸念された帯状疱疹後神経痛の
こともなかった。
After taking this drug for an additional week, she stopped taking it when healing of the eruption began, but she did not see any recurrence of the pain. She was concerned about postherpetic neuralgia. There was no.

【0024】(2)63歳の女子 胸部に痛みを覚え、2〜3日後米粒大の水疱を生じ、帯
状疱疹と診断された。治療(アシクロビル800mgづつ
を、毎食後、午後3時、及び就寝前の1日計5回)によ
り、皮疹は2週間後には治癒し始めたが、発疹以来の激
痛はその後も持続し、帯状疱疹後神経痛と診断された。
鎮痛剤(ジクロフェンナトリウム50mgづつ、毎食後1
日3回)が試みられたが、全く軽快の様相はなかった。
(2) 63-year-old woman Pain was felt in the chest, and after 2-3 days, a rice-grain-sized blister occurred, and she was diagnosed with shingles. Treatment (800mg each of acyclovir
And after each meal, by 3:00 pm, and before going to bed one day a total of five times), rash began to heal after two weeks, since the rash Pang then also persisted, diagnosed with post-herpetic neuralgia Was.
Painkiller (50 mg of diclofen sodium, 1 after each meal)
(Three times a day) was attempted, but there was no apparent relief.

【0025】皮疹治癒後半月を経てから、本発明医薬
0.25gの錠剤を1日3回各5錠経口服用したとこ
ろ、3日目から痛みは急速に軽減し、程なく消失した。
本剤約1か月服用して休薬したが、その後痛みの再発は
全くなかった。
After the second half of the healing of the eruption, the tablet of the present invention, 0.25 g, was orally taken three times a day, 5 tablets each, and the pain was rapidly reduced from the third day and disappeared soon.
After taking this drug for about one month and taking the drug off, there was no recurrence of pain.

【0026】(3)67歳女子 3年前胃癌の手術を受け、早期癌であったため全治して
いたが、口内炎の症状が断続、その後腹部に痛みを覚
え、水疱を生じて帯状疱疹と診断された。抗ウイルス剤
(アシクロビル800mgづつ、毎食後1日3回)と鎮痛
(チアプロフェン200mgづつ、毎食後1日3回)
による治療は1か月に及んだが、特にその痛みは激しく
かつ持続的であった。
(3) A 67-year-old girl had undergone surgery for gastric cancer three years ago and was completely cured because of her early cancer. However, her symptoms of stomatitis were intermittent, and her abdomen became painful. She developed blisters and was diagnosed with shingles. Was done. Antiviral agent
Treatment with acyclovir (800 mg, three times a day after each meal) and an analgesic (thiaprofen 200 mg, three times a day after each meal) lasted one month, but the pain was particularly severe and persistent. .

【0027】本剤の投与を、0.25g錠剤の1日3回
各4錠服用で開始した。10日後には痛みが著しく軽減
しかつ消失した。1か月服用し、その間に皮疹も治癒し
た。痛みの再発もなく、帯状疱疹後神経痛の症状も全く
見られなかった。
Administration of the drug was started by taking 0.25 g tablets three times a day four times each. After 10 days, the pain was significantly reduced and disappeared. I took it for one month, during which time the rash healed. There was no recurrence of pain and no signs of postherpetic neuralgia.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) A61K 35/78 CA(STN) CAOLD(STN) MEDLINE(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 6 , DB name) A61K 35/78 CA (STN) CAOLD (STN) MEDLINE (STN)

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 クロバナヒキオコシの植物体又はその抽
出物を含んで成る、帯状疱疹に起因する痛み及び/又は
苦しみの症状の緩和又は解消のための医薬。
1. A medicament for alleviating or eliminating the symptoms of pain and / or suffering caused by shingles, comprising a plant of black crab sprouts or an extract thereof.
【請求項2】 請求項1記載の植物体の乾燥粉末、顆粒
又はこれらを含む錠剤もしくはカプセル剤である、請求
項1に記載の医薬。
2. The medicament according to claim 1, which is a dry powder or granules of the plant according to claim 1, or a tablet or capsule containing them.
JP5337886A 1993-12-28 1993-12-28 Relief agent for shingles pain Expired - Fee Related JP2941160B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5337886A JP2941160B2 (en) 1993-12-28 1993-12-28 Relief agent for shingles pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5337886A JP2941160B2 (en) 1993-12-28 1993-12-28 Relief agent for shingles pain

Publications (2)

Publication Number Publication Date
JPH07188043A JPH07188043A (en) 1995-07-25
JP2941160B2 true JP2941160B2 (en) 1999-08-25

Family

ID=18312927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5337886A Expired - Fee Related JP2941160B2 (en) 1993-12-28 1993-12-28 Relief agent for shingles pain

Country Status (1)

Country Link
JP (1) JP2941160B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055861A (en) * 2014-07-04 2014-09-24 张明先 Traditional Chinese medicine for treating shingles and preparation method thereof
CN104127726A (en) * 2014-07-31 2014-11-05 赵涛 Pharmaceutical composition for treatment of herpes zoster
CN104922512A (en) * 2015-06-05 2015-09-23 包莉丽 Medicine for treating herpes zoster

Also Published As

Publication number Publication date
JPH07188043A (en) 1995-07-25

Similar Documents

Publication Publication Date Title
US10383843B2 (en) Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
WO2008112561A1 (en) Combination therapy for alleviating pain-related conditions
CN104983844A (en) Edible composition formula with mucous-membrane restoring function and preparation process of preparation thereof
CN100431593C (en) Chinese medicinal formulation for treating hydrocephalus
US20230125425A1 (en) Traditional chinese medicine extract composition with function of regulating depressive emotion and preparation method and traditional chinese medicine preparation thereof
JP2941160B2 (en) Relief agent for shingles pain
KR20150033797A (en) Pharmaceutical composition for prevention and treatment of atopic skin disease
US20090297643A1 (en) Botanical composition and its uses
CN114177160A (en) Foot patch for treating dental ulcer and preparation method thereof
KR20070002401A (en) Composition for preventing and treating inflammatory disease comprising glucosamine and pinitol
CN102743587A (en) External application wound repair liquid
CN112587596A (en) Pharmaceutical composition for treating lymphatic system diseases caused by deficiency fire phlegm stagnation
JP2958198B2 (en) Analgesic pharmaceutical composition
JPH02152926A (en) Brain edema depressant
CN106943390B (en) Application of the Strychnos nux-vomica aglycon in preparation prevention or treatment antiarrhythmic medicament
CN100333744C (en) Acne treating medicine
CN115429836B (en) Traditional Chinese medicine preparation for treating arrhythmia
SU449724A1 (en) Mukaltin Expectorant
KR20170043484A (en) Pharmaceutical composition for treating or improving arthritis comprising high amount of an active ingredient derived from herbal substances
CN105663959A (en) Traditional Chinese medicine preparation for nursing patient suffering from toothache and preparation method
CN116763834A (en) Traditional Chinese medicine composition and preparation for treating arthralgia as well as preparation method and application of traditional Chinese medicine composition and preparation
KR101427035B1 (en) Composition for treating acne
CN110721241A (en) Medicine for treating chronic pharyngitis and preparation method thereof
CN110559358A (en) A Chinese medicinal composition for treating gingival swelling and pain and oral ulcer, and its preparation method
CN102940737A (en) Medicine for treating toothache diseases

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080618

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees